SKF 40057-Z2 1,3-BIS<2-CARBOXYCHROMON-5-YLOXY>-2-HYDROXY

PROPANE, DISODIUM SALT/ DISODIUM CHROMOGLYCATE

SAC

WLN T66 BO EVJ CVQ GO1 2YQ &-NA- 2

IHQQ1 DOSE .5(IV) SURV  /  %INHIB 33/.05

IH1 DOSE 1(IV) SURV 6/6 %INHIB 80/.01

IH1 DOSE 2.5(IV) SURV  /  %INHIB 52/.01

IH2 DOSE 1(IV) SURV 6/6 HIST INHIB -9/NS SER INHIB -2/NS

AA2 200 SAL IP PV 0-1 0 BW -1 0 SURV 100 EXP 524

$$

*P$$

SKF D1223 2<P-CHLORO-A-(2-DIMETHYLAMINOETHYL)BENZYL>PYRIDINE/

CHLORPHENIRAMINE

SAC

WLN T6NJ BYR DG&2N1&1

IH1 DOSE 5(IV) SURV 4/4 %INHIB 18/NS

1H1 DOSE 10(IV) SURV 3/3 %INHIB 39/.01

IH2 DOOSE 2.5(IV) SURV 5/5 HIST INHIB 100/.01 SER INHIB 0/NS

IH2 DOSE 5(IV) SURV 5/5 HIST INHIB 100/.01 SER INHIB 44/.01

IH2 DOSE 10(IV) SURV 6/6 HIST INHIB 100/.01 SER INHIB 94/.01

AA1 3.7 TRAG-PO PV -3 0 0 BW 0 0 SURV 100 EXP DATE 6/24/69

SKF 735-I 2-<(2-DIMETHYLAMINOETHYL)(P-METHOXYBENZYL)AMINO>

PYRIDINE/MEPYRAMINE

SAC

WLN T6NJ BN1R DO1&2N1&622

IH1 DOSE 5(IV) SURV 6/6 %INHIB 42/.01

IH2 DOSE 5(IV) SURV 6/6 HIST INHIB 100/.01 SER INHIB 8/NS

AA2 17.8 H20 PO PV 0 0 -3 BW 0 0 SURV 100% EXP 381

PSKF 34790-Z GOLD SODIUM THIOMALATE/MYOCHRYSINE

SAC

WLN

IH1 DOSE 17.7  (IV) SURV 6/6 %INHIB 22/.01

IH2 DOSE 17.7(IV) SURV 6/6 HIST INHIB 10/NS SER INHIB 2/NS

AA2 20 BZAL IM PV -3-400 0 BW -3 0 SURV 50 SER AV 19.4 EXP 416

AA2 10 BZAL IM PV 0-4-1 BW 0 2 SURV 66.7 SER AV 10.4 EXP 416

AA2  5 BZAL IM PV 0-1 0 BW 0 0 SURV 100 SER AV 7.2 EXP 416

AA2 2.5 BZAL IM PV 0-1 --0 BW 0 0 SURV 66.7 SER AV -- EXP 416

$$

*P$$

PSKF 6149 ACETYLSALICYLIC ACID/ASPIRIN

SAC

WLN

IH1 DOSE 20(IV) SURV 6/6 55%INHIB -18/NS

IH2 DOSE 20(IV) SURV 6/6 HIST INHIB 12/NS SER INHIB -2/NS

AA1 400 TRAG PO PV -5-4-4 BW -3 001 SURV 87.5 EXP312

AA1 200 TRAG PO PV -5-4-3 BW 0 1 SURV 100 EXP 312

AA1 100 TRAG PO PV -4-30 BW 0 0 SURV 100 EXP 312

AA1  50 TRAG PO PV -4-30 BW -3 0 SURV 100 EXP 312

AA1 ED25 128.0(86-179) 154(107-219) 283(218-399) EXP312

AA1 ED25 193(120-358) 179(78-691) NOT ATTAINABLE EXP 258

AA1 ED25 97(64-39) 59(31-95) 227(61-3333) EXP 467

$$

*PSKF12408-A 1-METHYL-4-(5-DIBEZO-<A,E>-CYCLOHEPTATRIENYLIDENE)-

PIPERIDINE/CYPROHEPTADINE

SAC

WLN L C676 BYJ BU-DT6N DYTJ A &GH

IH1 DOSE 1(IV) SURV 4/4 %INHIB 71/.01

IH1 DOSE 2(IV) SURV 4/4 %INHIB 100/.01

IH2 DOSE .5(IV) SURV 6/6 HIST INHIB 65/.05 SER INHIB 30/.05

IH2 DOSE 2(IV) SURV 6/6 HIST INHIB 100/.01 SER INHIB 44/.01

AA1 9 TRAG PO PV -2 0 0 BW 0 0 SURV 100 EXP DATE 6/24/69

$$

*P$$

*P